NeuroStar® TMS Therapy
FDA-cleared, non-medication depression treatment
Existing Patients For Providers →
(855) 940-4867
Medically reviewed on 11/16/2020 by
Dr. Kimberly Cress
Texas Regional Medical Director
Do you have your father's nose or your mother's eyes? Perhaps stubbornness is a common family trait, or you all have a similar sense of humor. Many traits run in families, so it's natural to wonder, is depression genetic, too? Depression and genetics are correlated in some ways, but you are much more than your DNA. If you have a parent or sibling with depression, that doesn't mean you'll inevitably develop depression, too. In fact, recent research suggests you could even positively influence the genetic legacy you pass onto future generations.
Depression can sometimes arise in response to events in our lives: the COVID-19 pandemic, stress, chronic pain, or bereavement, for example. So, to what extent is depression genetic? Only 40 percent of the population's tendency toward depression can be explained by genes. There is no single gene for depression. At least 44 gene variants contribute to the risk of depression from one generation to the next, and research is ongoing to better understand. Even if you were to inherit many of these, you still might not develop depression. Instead, the chance depends on:
As a result, even if your child were to inherit all these genetic variants from you, he or she would not necessarily develop depression.
The genes identified in depression studies are integral parts of the nervous system. They influence how nerve cells grow and send signals to brain regions that influence mood. They control the function of chemical messengers called neurotransmitters (such as serotonin), which are altered in depression. Some genes influence the immune system, which is also linked to our mood. So, could you change the genetic code you pass onto future generations? Possibly. A relatively new scientific field called epigenetics explores how the events in our lives switch the expression—or readability—of our genes without changing the DNA code itself. These life events include early adversity in childhood, trauma, or prolonged stress. Tiny chemical tags are added to or removed from our DNA in response to these events. The chemical tags turn depression genes on or off.
Subsequently, epigenetic changes can be passed down to the next generation. That means it may be possible to pass on positive epigenetic changes by taking positive steps that actively support your health. These include surrounding yourself with strong social support, engaging in physical activity where possible, and treating symptoms of depression.
If you have a sibling or parent with depression, you have two to three times the chance of developing depression yourself. However, this isn't solely related to the DNA you share. We know this partly due to studies of identical twins. Even though they have almost no difference in their DNA, if one twin develops depression, the other twin frequently doesn't. Instead, it's our experience and environment that matter. Shared life experiences within families can often place closely related people at higher risk for depression. These shared experiences could include early adversity or neglect in childhood, trauma, family pressures, or addiction.
If you have depression just as another member of your family does, your shared experiences could also explain this, rather than your shared DNA. Further, depression often affects not only the person with depression, but their family, too. Family life can feel unsettled, compounded by the financial, social, and physical issues that accompany depression. Finding the right treatment could restore balance to your own life as well as the lives of your loved ones.
Thanks for subscribing to our list!
If you're ready to begin your treatment journey, empower yourself to take the next steps. Imagine waking up refreshed each morning with hope for the day ahead, passion for the interests you hold, and positive energy to see you through time spent with family and friends. If you have persistent stress, counseling might help you and your family. Consider speaking to your doctor about treating any underlying medical conditions, such as chronic pain or sleep apnea, that exacerbate depression. Or perhaps you'd benefit from an antidepressant medication. If those common approaches don't work, another way to break the cycle of depression and genetics is transcranial magnetic stimulation (TMS).
TMS therapy is a non-invasive and non-drug depression treatment that applies highly focused magnetic pulses to brain regions that are crucial in the regulation of mood. It's been cleared by the FDA for the treatment of Major Depressive Disorder and Obsessive Compulsive Disorder. TMS can help to relieve some, or even all, of the symptoms of depression in many patients. Whichever treatment path you choose, remember: even if depression has been part of your family's history, it doesn't need to be part of your future.
Take our short quiz to see if TMS therapy or nasal esketamine could be right for you
Subscribe for mental health, self-care, and TMS therapy and nasal esketamine updates for those affected by treatment-resistant depression or OCD.
Thank you for subscribing to our email list!
Oops, there was an error adding your subscription.
Please try again later.
By providing your email address, you are consenting to receive blog updates from Greenbrook TMS Inc. You may unsubscribe from these alerts at any time by following the “unsubscribe” link at the bottom of email alerts. At Greenbrook TMS Inc. we take the privacy and security of your personal information seriously. To learn more about how we protect your personal information, please refer to our Privacy Policy.
Greenbrook supports an accessible internet. If you have any questions about our accessibility features, please contact us at
(855) 940-4867 or info@greenbrooktms.com.
NeuroStar Adult Indications for Use
The NeuroStar Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode.
The NeuroStar Advanced Therapy System is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD).
NeuroStar Adolescent Indications for Use
NeuroStar Advanced Therapy is indicated as an adjunct for the treatment of Major Depressive Disorder (MDD) in adolescent patients (15-21).
Important Safety Information
NeuroStar Advanced Therapy is only available by prescription. A doctor can help decide if NeuroStar Advanced Therapy is right for you. Patients’ results may vary.
The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of TMS therapy (<0.1% per patient).
Visit neurostar.com for full safety and prescribing information.
Important Safety Information
What is the most important information I should know about SPRAVATO®?
SPRAVATO® can cause serious side effects, including:
Do not take SPRAVATO® if you:
If you are not sure if you have any of the above conditions, talk to your healthcare provider before taking SPRAVATO®.
Before you take SPRAVATO®, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines that you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. Taking SPRAVATO® with certain medicine may cause side effects.
Especially tell your healthcare provider if you take central nervous system (CNS) depressants, psychostimulants, or monoamine oxidase inhibitors (MAOIs) medicine. Keep a list of them to show to your healthcare provider and pharmacist when you get a new medicine.
How will I take SPRAVATO®?
What should I avoid while taking SPRAVATO®?
Do not drive, operate machinery, or do anything where you need to be completely alert after taking SPRAVATO®. Do not take part in these activities until the next day following a restful sleep. See “What is the most important information I should know about SPRAVATO®?”
What are the possible side effects of SPRAVATO®?
SPRAVATO® may cause serious side effects including:
See “What is the most important information I should know about SPRAVATO®?”
Increased blood pressure. SPRAVATO® can cause a temporary increase in your blood pressure that may last for about 4 hours after taking a dose. Your healthcare provider will check your blood pressure before taking SPRAVATO® and for at least 2 hours after you take SPRAVATO®. Tell your healthcare provider right away if you get chest pain, shortness of breath, sudden severe headache, change in vision, or seizures after taking SPRAVATO®.
Problems with thinking clearly. Tell your healthcare provider if you have problems thinking or remembering.
Bladder problems. Tell your healthcare provider if you develop trouble urinating, such as a frequent or urgent need to urinate, pain when urinating, or urinating frequently at night.
The most common side effects of SPRAVATO® include:
If these common side effects occur, they usually happen right after taking SPRAVATO® and go away the same day.
These are not all the possible side effects of SPRAVATO®.
Call your doctor for medical advice about side effects. You may report side effects to Johnson & Johnson at 1-800-526-7736, or to the FDA at 1-800-FDA-1088.
What is SPRAVATO® (esketamine) CIII nasal spray?
SPRAVATO® is a prescription medicine used:
SPRAVATO® is not for use as a medicine to prevent or relieve pain (anesthetic). It is not known if SPRAVATO® is safe or effective as an anesthetic medicine.
It is not known if SPRAVATO® is safe and effective for use in preventing suicide or in reducing suicidal thoughts or actions. SPRAVATO® is not for use in place of hospitalization if your healthcare provider determines that hospitalization is needed, even if improvement is experienced after the first dose of SPRAVATO®.
It is not known if SPRAVATO® is safe and effective in children.
Please see full Prescribing Information, including Boxed WARNINGS, and Medication Guide for SPRAVATO® and discuss any questions you may have with your healthcare provider.
All Rights Reserved | Greenbrook TMS NeuroHealth Centers.